Form 4 for MEDS DataMeds AI, Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-21 · accession 0001641172-25-000555 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-03-25 | 2025-03-21 | MEDS | Patel Prashant | Chief Strategy Off, Dir | A - Grant | $0.00 | +2.20M | 1.50M | New | $0 |
| 2025-03-25 | 2025-03-21 | MEDS | Patel Prashant | Chief Strategy Off, Dir | A - Grant | $0.00 | +1.88M | 4.12M | +84% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 700,000 | $0.00 | 700,000 | I | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. |
| 2 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 1,500,000 | $0.00 | 1,500,000 | I By Scietech LLC | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. |
| 3 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 1,882,247 | $0.00 | 4,118,247 | D By Akrias LLC | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. |